Circulatory soluble endoglin and its predictive value for preeclampsia in second-trimester pregnancies with abnormal uterine perfusion.

No abstract is available for this paper.

• Publication year

  2008

• Venue

  American Journal of Obstetrics and Gynecology

• Publication date

  2008-02-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/j.ajog.2007.08.052PMID 18226617
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Angiogenic growth factor levels in maternal and fetal blood: correlation with Doppler ultrasound parameters in pregnancies complicated by pre‐eclampsia and intrauterine growth restriction

  2007cited by this paper
• Changes in circulating level of angiogenic factors from the first to second trimester as predictors of preeclampsia.

  2007cited by this paper
• Predictive Value of Maternal Angiogenic Factors in Second Trimester Pregnancies With Abnormal Uterine Perfusion

  2007cited by this paper
• Soluble endoglin and other circulating antiangiogenic factors in preeclampsia

  2007cited by this paper
• Angiogenic factors and preeclampsia.

  2007cited by this paper
• Endoglin Has a Crucial Role in Blood Cell–Mediated Vascular Repair

  2006cited by this paper
• Placental angiogenic growth factors and uterine artery Doppler findings for characterization of different subsets in preeclampsia and in isolated intrauterine growth restriction.

  2006cited by this paper
• Soluble endoglin and other circulating antiangiogenic factors in preeclampsia.

  2006cited by this paper
• Soluble endoglin contributes to the pathogenesis of preeclampsia

  2006cited by this paper
• A combined technique for predicting pre-eclampsia: concurrent measurement of uterine perfusion and analysis of heart rate and blood pressure variability

  2006cited by this paper
• Circulating Angiogenic Factors in Preeclampsia

  2005cited by this paper
• Prediction of Preeclampsia

  2005cited by this paper
• Angiotensin II Type 1 Receptor Agonistic Antibodies Reflect Fundamental Alterations in the Uteroplacental Vasculature

  2005cited by this paper
• Pre-eclampsia

  2005cited by this paper
• Circulating angiogenic factors and the risk of preeclampsia.

  2004cited by this paper
• Urinary angiogenic factors cluster hypertensive disorders and identify women with severe preeclampsia.

  2004cited by this paper
• First trimester placental growth factor and soluble fms-like tyrosine kinase 1 and risk for preeclampsia.

  2004cited by this paper
• Antibiotic use in relation to the risk of breast cancer

  2004cited by this paper
• Maternal serum sFlt1 concentration is an early and reliable predictive marker of preeclampsia.

  2004cited by this paper
• Soluble fms-like tyrosine kinase 1.

  2004cited by this paper
• Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia.

  2003cited by this paper
• Overexpression of the soluble vascular endothelial growth factor receptor in preeclamptic patients: pathophysiological consequences.

  2003cited by this paper
• Longitudinal serum concentrations of placental growth factor: evidence for abnormal placental angiogenesis in pathologic pregnancies.

  2003cited by this paper
• Endothelial dysfunction and raised plasma concentrations of asymmetric dimethylarginine in pregnant women who subsequently develop pre-eclampsia.

  2003cited by this paper
• Second-trimester uterine artery Doppler screening in unselected populations: a review

  2002cited by this paper
• Screening for pre‐eclampsia and fetal growth restriction by uterine artery Doppler at 11–14 weeks of gestation

  2001cited by this paper
• Low maternal serum levels of placenta growth factor as an antecedent of clinical preeclampsia.

  2001cited by this paper
• Pre-eclampsia

  2000cited by this paper
• Report of the National High Blood Pressure Education Program Working Group on High Blood Pressure in Pregnancy.

  2000cited by this paper
• How useful is uterine artery Doppler flow velocimetry in the prediction of pre‐eclampsia, intrauterine growth retardation and perinatal death? An overview

  2000cited by this paper
• The myths of laparoscopic surgery.

  2000cited by this paper
• Defective angiogenesis in mice lacking endoglin.

  1999cited by this paper
• A Two‐Stage Screening Test for Pregnancy‐Induced Hypertension and Preeclampsia

  1998cited by this paper
• Computation of multifactorial receiver operator and predictive accuracy characteristics.

  1994cited by this paper
• National High Blood Pressure Education Program Working Group Report on Hypertension in Diabetes

  1994cited by this paper

• Late vs. Early Preeclampsia

  2025cites this paper
• Machine learning applied in maternal and fetal health: a narrative review focused on pregnancy diseases and complications

  2023cites this paper
• Proteomic profile of extracellular vesicles in maternal plasma of women with fetal death

  2023cites this paper
• Modern possibilities of prediction and early diagnosis of preeclampsia

  2021cites this paper
• Soluble endoglin concentration in maternal blood as a diagnostic biomarker of preeclampsia: A systematic review and meta-analysis.

  2021cites this paper
• Prediction of preeclampsia throughout gestation with maternal characteristics and biophysical and biochemical markers: a longitudinal study.

  2021cites this paper
• Review

  2021cites this paper
• Differential Secretion of Angiopoietic Factors and Expression of MicroRNA in Umbilical Cord Blood from Healthy Appropriate-For-Gestational-Age Preterm and Term Newborns—in Search of Biomarkers of Angiogenesis-Related Processes in Preterm Birth

  2020cites this paper
• Role of placenta in development of pre‐eclampsia: revisited

  2020cites this paper
• Renal biomarkers of preeclampsia

  2020cites this paper
• Combining Biomarkers to Predict Pregnancy Complications and Redefine Preeclampsia

  2020cites this paper
• Risk Factor and Biomarker of Preeclampsia

  2019cites this paper
• The prediction of early preeclampsia: Results from a longitudinal proteomics study

  2019cites this paper
• Evaluation of Serum Biomarkers and Other Diagnostic Modalities for Early Diagnosis of Preeclampsia

  2019cites this paper
• Clinical, Biochemical, and Biophysical Markers of Angiogenesis in Preeclampsia

  2019cites this paper
• Clinical Presentation of Preeclampsia and the Diagnostic Value of Proteins and Their Methylation Products as Biomarkers in Pregnant Women with Preeclampsia and Their Newborns

  2018cites this paper
• Possible connection between elevated serum α-fetoprotein and placental necrosis during pregnancy: A case report and review of literature

  2018cites this paper
• Plazentainsuffizienz/Plazentaassoziierte Erkrankungen

  2018cites this paper
• Role of Laeverin in the pathophysiology of preeclampsia

  2018cites this paper
• Integrated Systems Biology Approach Identifies Novel Maternal and Placental Pathways of Preeclampsia

  2018cites this paper
• Correlation between maternal serum-amniotic fluid anti-angiogenic factors and uterine artery Doppler indices

  2017cites this paper
• Increased cardiorespiratory coordination in preeclampsia

  2017cites this paper
• Antigen Analysis of Pre-Eclamptic Plasma Antibodies Using Escherichia Coli Proteome Chips *

  2017cites this paper
• Anti-angiogenesis and Preeclampsia in 2016

  2017cites this paper
• Metformin, the aspirin of the 21st century: its role in gestational diabetes mellitus, prevention of preeclampsia and cancer, and the promotion of longevity

  2017cites this paper
• Angiogenic and antiangiogenic factors in preeclampsia.

  2017cites this paper
• Prediction and prevention of hypertensive disorders of pregnancy

  2017cites this paper
• Prospects of electrochemical immunosensors for early diagnosis of preeclampsia

  2017cites this paper
• Chapter Fourteen – Biomarkers in Preeclampsia

  2017cites this paper
• Clinical risk factors for pre-eclampsia determined in early pregnancy: systematic review and meta-analysis of large cohort studies

  2016cites this paper
• Endoglin (CD105) coordinates the process of endometrial receptivity for embryo implantation.

  2016cites this paper
• Relationship of Liver X Receptors α and Endoglin Levels in Serum and Placenta with Preeclampsia

  2016cites this paper
• Serum C3 and uterine artery Doppler indices at 14-20 weeks gestation for preeclampsia screening in low-risk primigravidas: A prospective observational study.

  2016cites this paper
• Quantification de la vascularisation de l'unité utéro-placentaire par Doppler 3D : évaluation clinique et expérimentale

  2016cites this paper
• The role of microRNAs on angiogenesis and vascular pressure in preeclampsia: The evidence from systematic review

  2015cites this paper
• Update on the Pathophysiological Implications and Clinical Role of Angiogenic Factors in Pregnancy

  2015cites this paper
• Angiogenic biomarkers in pregnancy: defining maternal and fetal health

  2015cites this paper
• Chapter 11 – Tests to Predict Preeclampsia

  2015cites this paper
• Angiogenic factors and uterine Doppler velocimetry in early‐ and late‐onset preeclampsia

  2014cites this paper
• Angiogenic factors in diagnosis, management, and research in preeclampsia.

  2014cites this paper
• Endoglin in liver fibrogenesis: Bridging basic science and clinical practice World Journal of Biological Chemistry W

  2014cites this paper
• Placenta-derived angiogenic proteins and their contribution to the pathogenesis of preeclampsia

  2014cites this paper
• Low-Molecular Weight Heparin Increases Circulating sFlt-1 Levels and Enhances Urinary Elimination

  2014cites this paper
• Prediction of Early-Onset Preeclampsia Using Uterine Artery Doppler

  2014cites this paper
• Der automatisierte Elecsys®-Assay zur Messung von sFlt1, PlGF und ihrem Quotienten sFlt1/PlGF in der Diagnose hypertensiver Schwangerschaftserkrankungen

  2014cites this paper
• ¿Es el factor de crecimiento nervioso (NGF) un marcador útil durante el embarazo para la predicción de preeclampsia precoz?

  2014cites this paper
• Serum Markers for the Prediction of Preeclampsia

  2014cites this paper
• Clinical applications of biomarkers in preeclampsia.

  2014cites this paper
• Endoglin in liver fibrogenesis: Bridging basic science and clinical practice.

  2014cites this paper
• Second- and third-trimester biochemical and ultrasound markers predictive of ischemic placental disease.

  2014cites this paper
• [Evaluation of the usefulness of endoglin level as a predictor of preeclampsia in pregnant women with hypertension].

  2013cites this paper
• The levels of angiogenic and anti-angiogenic molecule concentrations in pregnancy based disorders in the maternal and fetal circulation

  2013cites this paper
• The role and challenges of biomarkers in spontaneous preterm birth and preeclampsia.

  2013cites this paper
• Endoglin in Amniotic Fluid as a Risk Factor for the Subsequent Development of Bronchopulmonary Dysplasia

  2013cites this paper
• Emerging new biomarkers of preeclampsia.

  2013cites this paper
• Classification of cardiovascular time series based on different coupling structures using recurrence networks analysis

  2013cites this paper
• The severity of hypoxic changes and oxidative DNA damage in the placenta of early-onset preeclamptic women and fetal growth restriction

  2013cites this paper
• Classifying healthy women and preeclamptic patients from cardiovascular data using recurrence and complex network methods.

  2013cites this paper
• Fetal hemoglobin in preeclampsia: a new causative factor, a tool for prediction/diagnosis and a potential target for therapy

  2013cites this paper
• Who is (not) at risk? Prognostic tests and models in obstetrics with a focus on pre-eclampsia and preterm birth

  2013cites this paper
• Prediction of the preeclampsia: a view of biochemical markers

  2013influential citation
• Recent biomarkers for the identification of patients at risk for preeclampsia: the role of uteroplacental ischemia.

  2012influential citation
• Angiogenic growth factors in the diagnosis and prediction of pre-eclampsia.

  2012cites this paper
• Classifying Healthy and Preeclamptic Patients from Recurrence-Based Cardiovascular Time Series Using Complex Networks Methods

  2012cites this paper
• The promise of angiogenic markers for the early diagnosis and prediction of preeclampsia.

  2012cites this paper
• Influence of so far neglected psychosomatic factors, BMI and smoking on pregnancy-induced hypertension (PIH).

  2012cites this paper
• Placenta related pathogenic factors for preeclampsia

  2012cites this paper
• Late-onset preeclampsia is associated with an imbalance of angiogenic and anti-angiogenic factors in patients with and without placental lesions consistent with maternal underperfusion

  2012cites this paper
• A Comprehensive Review of Hypertension in Pregnancy

  2012cites this paper
• An overview of recent advances in pathogenesis and diagnosis of preeclampsia.

  2012cites this paper
• Cell Free Expression of hif1α and p21 in Maternal Peripheral Blood as a Marker for Preeclampsia and Fetal Growth Restriction

  2012cites this paper
• Early Detection of Maternal Risk for Preeclampsia

  2012cites this paper
• Marqueurs biologiques de la prééclampsie

  2012cites this paper
• Accuracy of circulating placental growth factor, vascular endothelial growth factor, soluble fms‐like tyrosine kinase 1 and soluble endoglin in the prediction of pre‐eclampsia: a systematic review and meta‐analysis

  2012cites this paper
• Angiogenic factors and preeclampsia.

  2011cites this paper
• Pre‐eclampsia: a maternal manifestation of a fetal adaptive response?

  2011cites this paper
• A Critical Review of Early-Onset and Late-Onset Preeclampsia

  2011cites this paper
• Relation Between Maternal Angiogenic Factors and Utero-Placental Resistance in Normal First- and Second-Trimester Pregnancies

  2011cites this paper
• Maternal plasma concentrations of angiogenic/anti-angiogenic factors are of prognostic value in patients presenting to the obstetrical triage area with the suspicion of preeclampsia

  2011cites this paper
• [Combining biochemical and ultrasonographic markers in predicting preeclampsia: a systematic review].

  2011cites this paper
• Circulating predictive biomarkers in preeclampsia.

  2011influential citation
• Biochemical markers for prediction of preclampsia: review of the literature.

  2011cites this paper
• Contemporary prediction of preeclampsia

  2011cites this paper
• Biomarkers in Preeclampsia

  2011cites this paper
• Maternal nutrition and the risk of preeclampsia

  2011cites this paper
• Hellp Syndrome: Review

  2011cites this paper
• Circulating angiogenic and antiangiogenic factors in women with eclampsia.

  2011cites this paper
• Pregnancy Hypertension : An International Journal of Women ’ s Cardiovascular Health

  2011influential citation
• Plasma soluble endoglin concentration in pre‐eclampsia is associated with an increased impedance to flow in the maternal and fetal circulations

  2010cites this paper
• The preeclampsia biomarkers soluble fms-like tyrosine kinase-1 and placental growth factor: current knowledge, clinical implications and future application.

  2010cites this paper
• Abnormal placentation, angiogenic factors, and the pathogenesis of preeclampsia.

  2010cites this paper
• Angiogenic proteins as aid in the diagnosis and prediction of preeclampsia

  2010cites this paper
• Preeclampsia and pregnancies with small-for-gestational age neonates have different profiles of complement split products

  2010cites this paper
• Biomarkers in Obstetric Medicine

  2010cites this paper
• Serum and plasma determination of angiogenic and anti-angiogenic factors yield different results: The need for standardization in clinical practice

  2010cites this paper
• Combining biochemical and ultrasonographic markers in predicting preeclampsia: a systematic review.

  2010cites this paper
• First‐trimester assessment of placenta function and the prediction of preeclampsia and intrauterine growth restriction

  2010cites this paper
• Effects of hypoxia-inducible factor-1alpha overexpression in pregnant mice: possible implications for preeclampsia and intrauterine growth restriction.

  2010cites this paper
• An imbalance between angiogenic and anti-angiogenic factors precedes fetal death in a subset of patients: results of a longitudinal study

  2010cites this paper
• Hypertension in Pregnancy: List of abbreviations

  2010cites this paper